Clinical Trial Detail

NCT ID NCT03504644
Title Venetoclax and Vincristine Liposomal in Treating Patients With Relapsed or Refractory T-cell or B-cell Acute Lymphoblastic Leukemia
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors ECOG-ACRIN Cancer Research Group
Indications

acute lymphoblastic leukemia

Therapies

Venetoclax + Vincristine Sulfate

Age Groups: adult senior

No variant requirements are available.